Anaphylaxis and Cardiac Arrhythmias: What Is There to Fear?
Ultimately, epinephrine should not be withheld for the treatment of anaphylaxis in patients with long QT syndrome, although certain precautions should be heeded.
Allergies
ALLERGIES
FEATURED
LATEST FEATURES
FDA Committee Votes on AR101 for Peanut Allergy
The FDA’s Allergenic Products Advisory Committee voted in favor of the approval of Palforzia (AR101) as a treatment to reduce the incidence and severity of allergic reactions.
Pediatric Peanut Allergies Safely Desensitized With Sublingual Immunotherapy
Extended peanut sublingual immunotherapy for up to 5 years was safe and showed evidence of immune modulation.
AERD Last in Gradual Progression of Allergic Disease Diagnoses
Among patients with aspirin-exacerbated respiratory disease, there appears to be a gradual progression from asthma to nasal polyps and then to aspirin sensitivity.
LATEST NEWS
Allergy Immunotherapy May Decrease Risk for Asthma Progression
Allergy immunotherapy is associated with a decreased risk for asthma progression, particularly in younger patients.
ATS Guideline Outlines Diagnostic Tests for Pulmonary Fungal Infections
The guideline addresses laboratory testing for diagnosis of fungal infections in pulmonary medicine and critical care.
Benralizumab Receives Orphan Drug Status for Eosinophilic Esophagitis
The FDA has granted Orphan Drug designation to benralizumab for the treatment of eosinophilic esophagitis.
Long-Term Dupilumab Therapy Shows Sustained Improvements in Atopic Dermatitis Symptoms
The safety and efficacy profile from this study supports the role of dupilumab as continuous long-term treatment for patients with moderate to severe atopic dermatitis.
Psychological Distress in Allergic Diseases: Risk Factors, Prevalence
Relatively low levels of serious psychological distress were observed in a cohort of Australian young adults with a high prevalence of allergic diseases.
Atopic Dermatitis Associated With Frequent Cutaneous Comorbidity
Cutaneous comorbidity is frequent in those with atopic dermatitis, suggesting the need for comprehensive, dermatologically guided diagnostics.
FDA-Approved Generic Version of EpiPen Jr Now Available
The FDA-approved generic version of EpiPen Jr (epinephrine injection; Mylan) Auto-Injector 0.15mg is now available.
Biologics License Application for Peanut Allergy Patch Resubmitted to FDA
The BLA had initially been submitted in October 2018 but was withdrawn after the FDA cited concerns over manufacturing procedures and quality controls.
Want to read more?
Please login or register first to view this content.
Next post in Allergies
